用户，您好！欢迎您进入重大新药创制—内分泌代谢平台！
请
登录
|
注册
NSTL重点领域信息门户
帮助中心
RSS
重点领域信息门户
重大新药创制—内分泌代谢
首页
资源分析
重点信息源
用户空间
高级检索
期刊浏览
您当前的位置：
首页
>
资源分析
来源机构
糖尿病护理(1,374)
DIABETOLOGIA?(687)
糖尿病(562)
t糖尿病(496)
糖尿病肥胖和代谢(412)
临床内分泌学与代谢杂志(275)
细胞代谢(126)
肥胖综述(85)
抗氧化剂和氧化还原信号(84)
当前脂质研究观点(65)
自由基生物与医学(63)
内分泌和代谢趋势(57)
骨和矿物质研究杂志(47)
心理神经内分泌学(36)
柳叶刀-糖尿病和内分泌(24)
内分泌综述(21)
自然内分泌学综述(20)
松果体研究杂志(16)
神经内分泌学前沿(14)
国际肥胖期刊和相关代谢紊乱杂志(2)
国家或组织
美国(1,745)
韩国(1,439)
德国(687)
英国(595)
机构类别
期刊(4,430)
国际重要组织(36)
资源性质
科技论文(4,446)
重要新闻(20)
监测目标对象
BMI(6)
抽取对象
American Diabetes Association(204)
Diabetes(203)
diabetes(189)
type 2 diabetes(161)
the American Diabetes Association(156)
Diabetes Care(149)
first(115)
CrossRef(114)
PubMed(113)
Article Information(112)
OpenUrl Abstract(111)
OpenUrl(109)
type 1 diabetes(106)
insulin resistance(100)
Duality of Interest(99)
Download(98)
al(98)
al ..(88)
glucose(87)
Info & Metrics(86)
obesity(85)
PDF(76)
cardiovascular(75)
hyperglycemia(72)
BMI(71)
CI(67)
HbA1c(67)
Science ?(67)
cardiovascular disease(67)
obese(67)
JM(65)
diabetic(65)
Contributions(64)
U.S.(58)
secretion(58)
Acknowledgments(57)
hypoglycemia(55)
K (54)
L (54)
N Engl J Med(54)
CA(53)
liver(53)
D (51)
OpenUrl CrossRef(51)
β-cell(50)
hepatic(48)
hypertension(48)
Glucose(47)
Next Back(46)
DOI(45)
Metab(45)
diabetes mellitus(45)
Type 2 Diabetes(44)
View(44)
tissue(44)
Insulin(41)
second(41)
ME(40)
Novo Nordisk(39)
genetic(39)
metformin(39)
Fig(38)
Next (38)
Type 1 Diabetes(38)
Chen(37)
Digestive(37)
First(37)
Lancet Diabetes Endocrinol(37)
National Institutes of Health(37)
OpenUrl FREE(37)
blood(37)
RA(36)
RR(36)
JA(35)
MA(35)
renal(35)
METHODS(34)
fat(34)
vascular(34)
weight loss(34)
American(33)
Clinical(33)
dyslipidemia(33)
type 2 diabetes mellitus(33)
JL(32)
JM (32)
U.K.(32)
glucose tolerance(32)
Obesity(31)
?(30)
AL (30)
Clin Endocrinol(30)
DR(30)
J Clin Invest(30)
JAMA(30)
PLoS One(30)
T2D(30)
islet(30)
pregnancy(30)
skeletal muscle(30)
EJ(29)
Jun(29)
K(29)
L(29)
MD(29)
Physiology(29)
Sanofi(29)
Sci(29)
type 1 diabetes mellitus(29)
D(28)
LA(28)
muscle(28)
overweight(28)
prediabetes(28)
II(27)
MJ(27)
Next Back(27)
SJ(27)
Second(27)
blood pressure(27)
G (26)
JC(26)
RJ(26)
infarction(26)
stroke(26)
Lee(25)
MJ (25)
NJ(25)
RNA(25)
Research Design(25)
retinopathy(25)
AJ(24)
AstraZeneca(24)
H (24)
HDL(24)
JS(24)
NIH(24)
Nat Rev(24)
RS(24)
T1D(24)
adipocytes(24)
heart failure(24)
1C(23)
Eli Lilly(23)
F(23)
Methods.(23)
RA (23)
SA(23)
Summary(23)
coronary artery disease(23)
the National Institutes of Health(23)
weight gain(23)
Am J Physiol(22)
BMJ(22)
C-peptide(22)
DK(22)
JE (22)
OpenUrl View Abstract(22)
PA(22)
Supplementary Data(22)
Table 1(22)
cholesterol(22)
chronic kidney disease(22)
endocrine(22)
AR(21)
Australia(21)
Biol Chem(21)
Boehringer Ingelheim(21)
China(21)
Clin(21)
Germany(21)
Hypertension(21)
JF(21)
Japan(21)
KM (21)
Kim(21)
Supplementary Fig(21)
X (21)
impaired glucose tolerance(21)
insulin therapy(21)
m2(21)
ANOVA(20)
Anderson(20)
LM(20)
Lachin(20)
Mol(20)
Next(20)
SD(20)
SR(20)
SS(20)
US(20)
Xu(20)
albumin(20)
brain(20)
dapagliflozin(20)
diabetes care(20)
diabetic retinopathy(20)
disease(20)
microvascular(20)
pancreas(20)
the National Institute of Diabetes(20)
the United States(20)
third(20)
β-cells(20)
ACE(19)
CJ (19)
CVD(19)
DS(19)
Diabetes Care 2014(19)
European(19)
GLP-1(19)
HA(19)
JDRF(19)
JR (19)
MM(19)
Merck(19)
RC(19)
RJ (19)
SE(19)
SJ (19)
Student(19)
United States(19)
adipose(19)
glucagon(19)
heart(19)
kidney(19)
Briefly(18)
Canada(18)
JP (18)
Jul(18)
KB(18)
MI(18)
Merck Sharp & Dohme(18)
NC(18)
OpenUrl ?(18)
OpenUrl Abstract / FREE(18)
R01(18)
Third(18)
Zhou(18)
atherosclerosis(18)
cardiac(18)
gestational diabetes mellitus(18)
kidney disease(18)
total cholesterol(18)
Abbott(17)
American Heart Association(17)
BP(17)
CJ(17)
California(17)
Cardiovascular(17)
Diabetologia(17)
Endocrine Society(17)
F (17)
JW(17)
PA (17)
RM (17)
Roche(17)
SK (17)
SM (17)
San Francisco(17)
Supplementary Table 1(17)
View Abstract(17)
cancer(17)
coronary heart disease(17)
glucose intolerance(17)
gut(17)
http://www.diabetesjournals.org/content/license.View Abstract(17)
ketoacidosis(17)
mice(17)
AD(16)
BM(16)
Blood Institute(16)
CGM(16)
Dapagliflozin(16)
Diabet Med(16)
GA(16)
H(16)
IN(16)
Janssen(16)
NM(16)
Nathan(16)
Novartis(16)
OpenUrl FREE (16)
OpenUrl PubMed(16)
Pregnancy(16)
Scientific Sessions(16)
Statistical Analysis(16)
TA(16)
UK(16)
Youth(16)
absorption(16)
apoptosis(16)
endothelial(16)
hyperlipidemia(16)
macrophage(16)
pancreatic islets(16)
receptor(16)
’s(16)
Amgen(15)
ClinicalTrials.gov(15)
Colorado(15)
Congress(15)
Davis(15)
Diabetes Mellitus(15)
EDIC(15)
EW(15)
JB (15)
JP(15)
JS (15)
Jr (15)
Korea(15)
LM (15)
LS(15)
Lung(15)
ML(15)
NASH(15)
Nat Med(15)
National Institute of Diabetes(15)
Pfizer(15)
Physiol(15)
RL(15)
RM(15)
S (15)
San Diego(15)
T2DM(15)
WC(15)
hepatocytes(15)
insulin-dependent diabetes mellitus(15)
plasma(15)
6 years(14)
AH (14)
AP(14)
Atherosclerosis(14)
Cambridge(14)
Complications(14)
Cox(14)
DCCT(14)
Diabetes Control(14)
G(14)
HC(14)
Hispanic(14)
J Med(14)
KL(14)
Liver(14)
London(14)
MF(14)
Max Bingham(14)
Nat Commun(14)
RG(14)
SM(14)
Supplementary Table 2(14)
WA(14)
Wu(14)
adipocyte(14)
end-stage renal disease(14)
infection(14)
insulin-resistant(14)
leptin(14)
macrophages(14)
neuropathy(14)
nonalcoholic steatohepatitis(14)
retinal(14)
type 2 diabetic(14)
3E(13)
A1C(13)
AA(13)
AJ (13)
Akt(13)
Asian(13)
Clin Pract(13)
DA (13)
Denmark(13)
Diet(13)
ELISA(13)
Endocrine(13)
FL(13)
HA (13)
HFD(13)
HOMA-IR(13)
Hong Kong(13)
J(13)
J (13)
KA(13)
L.(13)
Mathieu(13)
N (13)
Orlando(13)
PJ (13)
SAS(13)
SC (13)
SGLT(13)
T cells(13)
Thomas(13)
al.(13)
autoimmune(13)
depression(13)
diabetic kidney disease(13)
diabetic nephropathy(13)
hyperglycemic(13)
mouse(13)
AB(12)
ADA(12)
AMPK(12)
American Association(12)
Atlanta(12)
Bayer(12)
Bristol-Myers Squibb(12)
CC(12)
CP(12)
Canagliflozin(12)
Clin Nutr(12)
DEPICT-1(12)
DP(12)
Europe(12)
France(12)
GJ(12)
GS(12)
J Am Coll Cardiol(12)
JB(12)
JH (12)
JK(12)
Johnson(12)
LA (12)
LS (12)
ME (12)
ML (12)
MS(12)
Michigan(12)
Nine(12)
PM (12)
Plasma(12)
Proc Natl Acad Sci U S A(12)
TA (12)
VA(12)
WH(12)
Web of Science(12)
atherosclerotic(12)
coronary artery(12)
dementia(12)
fibrosis(12)
insulin glargine(12)
murine(12)
nephropathy(12)
secondary(12)
the Diabetes Control and Complications Trial (DCCT(12)
4,5(11)
60 mL/min/1.73(11)
AA (11)
Americans(11)
CH(11)
Centers for Disease Control and Prevention(11)
Communities(11)
DCCT/EDIC Research Group(11)
DG(11)
DW(11)
Diabetologia 2016(11)
EA(11)
ES(11)
Fourth(11)
GDM(11)
GM(11)
GWAS(11)
Gao(11)
GlaxoSmithKline(11)
HJ(11)
Insulin resistance(11)
Intern Med(11)
James(11)
KD(11)
KJ(11)
KR(11)
M.S.(11)
MACE(11)
MC(11)
MG(11)
OpenUrl CrossRef PubMed(11)
PD(11)
Proc Natl Acad(11)
Rosenstock(11)
Sci U S(11)
T-cell(11)
Table 2(11)
The relationship(11)
Thermo Fisher Scientific(11)
Type 1 diabetes(11)
U (11)
U.K(11)
University of Washington(11)
X(11)
antihypertensive(11)
autoimmunity(11)
cardiovascular diseases(11)
coronary(11)
creatinine(11)
hepatic steatosis(11)
interplay(11)
kidneys(11)
liraglutide(11)
pancreatic β-cells(11)
renal disease(11)
监测主题
blood glucose(68)
blood sugar(2)
抽取主题
increased risk(111)
insulin resistance(72)
body weight(61)
glycemic control(57)
glucose tolerance(55)
insulin sensitivity(55)
high risk(52)
high-fat diet(51)
weight loss(51)
cardiovascular disease(47)
adipose tissue(46)
skeletal muscle(46)
glucose metabolism(41)
glycaemic control(38)
glucose intolerance(37)
glucose homeostasis(35)
plasma glucose(35)
insulin secretion(34)
oxidative stress(31)
physical activity(31)
metabolic syndrome(29)
lipid metabolism(28)
electronic supplementary material(27)
significant increase(27)
cardiovascular risk(26)
weight gain(26)
significant difference(24)
significant reduction(23)
systolic blood pressure(23)
bariatric surgery(22)
impaired glucose tolerance(22)
myocardial infarction(22)
mouse model(21)
protein expression(21)
blood pressure(20)
risk factor(20)
all-cause mortality(19)
beneficial effect(19)
clinical research(19)
fatty acid(19)
improved glucose tolerance(19)
increased expression(19)
waist circumference(19)
gene expression(18)
reactive oxygen species(18)
significant decrease(18)
significant effect(18)
transcription factor(17)
clinical care(16)
family history(16)
fat mass(16)
glucose control(16)
intensive lifestyle intervention(16)
mitochondrial function(16)
sensitivity analysis(16)
statistical analysis(16)
body composition(15)
energy expenditure(15)
fasting glucose(15)
hepatic steatosis(15)
mitochondrial dysfunction(15)
reduced risk(15)
informed consent(14)
low risk(14)
lower risk(14)
natural history(14)
normal glucose tolerance(14)
statistical significance(14)
clinical trial(13)
data collection(13)
diet-induced obesity(13)
high glucose(13)
metabolic control(13)
diabetic ketoacidosis(12)
energy homeostasis(12)
glucose uptake(12)
health care(12)
heart failure(12)
high prevalence(12)
increasing evidence(12)
positive association(12)
postprandial glucose(12)
protein kinase(12)
randomized controlled trial(12)
causal relationship(11)
coronary heart disease(11)
disease progression(11)
endoplasmic reticulum(11)
energy metabolism(11)
growing body(11)
hepatic glucose production(11)
improved insulin sensitivity(11)
lipid oxidation(11)
marked increase(11)
metabolic health(11)
precision medicine(11)
protective effect(11)
relative contribution(11)
renal disease(11)
significant change(11)
significant improvement(11)
supporting information(11)
therapeutic potential(11)
article content(10)
cell death(10)
chronic kidney disease(10)
continuous glucose monitoring(10)
cumulative incidence(10)
data show(10)
disease duration(10)
disease process(10)
endogenous glucose production(10)
endothelial function(10)
energy intake(10)
fatty acid oxidation(10)
fatty liver disease(10)
glucose cotransporter(10)
growth hormone(10)
independent risk factor(10)
intensive treatment(10)
lifestyle intervention(10)
metabolic regulation(10)
novo lipogenesis(10)
oral glucose tolerance(10)
recent-onset type(10)
statistical power(10)
written informed consent(10)
basal insulin(9)
blood glucose concentration(9)
body fat(9)
chronic inflammation(9)
clinical data(9)
cognitive function(9)
direct comparison(9)
genetic risk(9)
glucose infusion rate(9)
gold standard(9)
healthy control(9)
incident type(9)
increased incidence(9)
insulin action(9)
lifestyle modification(9)
lipid profile(9)
liquid nitrogen(9)
mass spectrometry(9)
median follow-up(9)
medical history(9)
metabolic phenotype(9)
negative regulator(9)
peroxisome proliferator(9)
position statement(9)
potential target(9)
receptor agonist(9)
risk stratification(9)
significant association(9)
significant interaction(9)
vascular endothelial growth factor(9)
blood flow(8)
cardiovascular mortality(8)
clear evidence(8)
data analysis(8)
diastolic blood pressure(8)
energy balance(8)
excess risk(8)
fasting plasma glucose(8)
food intake(8)
gastrointestinal tract(8)
glucagon-like peptide(8)
glucagon-like peptide-1(8)
high rate(8)
impaired fasting glucose(8)
individual patient(8)
islet function(8)
key component(8)
key regulator(8)
leading cause(8)
lipid accumulation(8)
longer duration(8)
mammalian target(8)
marked reduction(8)
metabolic disease(8)
nitric oxide(8)
normal glucose(8)
potential mechanism(8)
progressive loss(8)
rapid increase(8)
similar pattern(8)
statistically significant difference(8)
subcutaneous adipose tissue(8)
abstract form(7)
adipocyte differentiation(7)
cardiovascular safety(7)
cell proliferation(7)
cell surface(7)
cell survival(7)
chronic disease(7)
convincing evidence(7)
differential expression(7)
effective treatment(7)
energy restriction(7)
evidence-based treatment(7)
ex vivo(7)
fat distribution(7)
fatty liver(7)
fetal growth(7)
genetic background(7)
genetic variant(7)
glucose disposal(7)
glucose production(7)
glucose-lowering medication(7)
glycemic variability(7)
growing evidence(7)
growth factor(7)
heart rate(7)
hepatic gluconeogenesis(7)
high fat diet(7)
human type(7)
increased plasma(7)
increased susceptibility(7)
inflammatory response(7)
intensive glucose(7)
intensive glycemic control(7)
intensive therapy(7)
islet transplantation(7)
linear regression(7)
logistic regression(7)
long-standing type(7)
long-term treatment(7)
mean value(7)
mean ±(7)
microvascular disease(7)
mitochondrial activity(7)
new-onset type(7)
next-generation sequencing(7)
nonalcoholic fatty liver disease(7)
novel approach(7)
novel therapeutic target(7)
oxygen consumption(7)
patient care(7)
peripheral blood(7)
peripheral insulin sensitivity(7)
potential impact(7)
rat model(7)
solid line(7)
subgroup analysis(7)
systemic inflammation(7)
therapeutic strategy(7)
weight change(7)
alcohol consumption(6)
blood glucose control(6)
cardiometabolic risk(6)
cardiovascular death(6)
cardiovascular disease risk(6)
cell type(6)
childhood obesity(6)
cognitive performance(6)
collaborative meta-analysis(6)
continuous glucose(6)
correlation coefficient(6)
cytokine production(6)
data implicate(6)
detrimental effect(6)
diabetic nephropathy(6)
diabetic retinopathy(6)
different cell(6)
direct effect(6)
disease onset(6)
double-blind trial(6)
endothelial dysfunction(6)
experimental evidence(6)
first-line treatment(6)
flow cytometry(6)
gene expression profile(6)
genetic predisposition(6)
genetic risk score(6)
glucose variability(6)
high expression(6)
human islet(6)
human skeletal muscle(6)
incidence rate(6)
increased adiposity(6)
increased mortality(6)
increased type(6)
insulin tolerance(6)
insulin-stimulated glucose uptake(6)
inverse relationship(6)
islet autoimmunity(6)
key player(6)
kidney disease(6)
lactic acidosis(6)
life expectancy(6)
lipid synthesis(6)
liquid chromatography(6)
long-term follow-up(6)
long-term safety data(6)
longitudinal data(6)
low-grade inflammation(6)
maternal obesity(6)
medical care(6)
metabolic flexibility(6)
metabolic homeostasis(6)
metabolic response(6)
metformin therapy(6)
mitochondrial biogenesis(6)
molecular mechanism(6)
negative impact(6)
neutral effect(6)
novel mechanism(6)
novel strategy(6)
nuclear factor(6)
original research(6)
paraventricular nucleus(6)
peripheral neuropathy(6)
placebo-controlled trial(6)
plasma membrane(6)
positive correlation(6)
positive effect(6)
potential bias(6)
potential therapeutic target(6)
predictive value(6)
proliferator-activated receptor(6)
randomised clinical trial(6)
rate-limiting enzyme(6)
regulatory approval(6)
related content(6)
relative importance(6)
renal failure(6)
renal function(6)
residual confounding(6)
serum cholesterol(6)
serum glucose(6)
severe hypoglycaemia(6)
severe insulin resistance(6)
shorter duration(6)
survival analysis(6)
therapeutic target(6)
underlying mechanism(6)
visceral adipose tissue(6)
weight reduction(6)
western blot(6)
western blotting(6)
2-h glucose(5)
acute effect(5)
adipose tissue inflammation(5)
advanced glycation end(5)
analyzed data(5)
animal model(5)
autoimmune destruction(5)
beneficial metabolic(5)
blood pressure control(5)
blot analysis(5)
body weight loss(5)
bone marrow(5)
caloric restriction(5)
cardiorespiratory fitness(5)
cardiovascular outcome(5)
carotid intima-media thickness(5)
cell viability(5)
chronic exposure(5)
chronic treatment(5)
clinical benefit(5)
combination therapy(5)
compelling evidence(5)
compensatory increase(5)
comprehensive assessment(5)
concomitant increase(5)
considerable variation(5)
consummatory lordosis quotient(5)
coronary artery disease(5)
dark cycle(5)
design 48h(5)
dietary intake(5)
estimated glomerular filtration rate(5)
fat accumulation(5)
fat storage(5)
fatty acid synthesis(5)
female sexual desire(5)
gastric inhibitory(5)
genetic variation(5)
glomerular filtration rate(5)
glucose monitoring(5)
glucose transporter(5)
glucose utilisation(5)
glycogen content(5)
gradual increase(5)
gut microbiome(5)
hepatic glucose output(5)
high proportion(5)
hospital admission(5)
human obesity(5)
hypoactive sexual desire disorder(5)
increased energy expenditure(5)
increased physical activity(5)
increased serum(5)
increasing awareness(5)
increasing prevalence(5)
incremental area(5)
insulin receptor(5)
insulin release(5)
insulinotropic polypeptide(5)
key enzyme(5)
key mediator(5)
key question(5)
latent autoimmune(5)
linear relationship(5)
liver steatosis(5)
long-term safety(5)
lower blood glucose(5)
lower rate(5)
magnetic resonance(5)
mechanistic insight(5)
mechanistic target(5)
medical treatment(5)
mental health(5)
metabolic function(5)
metabolic risk(5)
mitochondrial content(5)
mitochondrial respiration(5)
mitogen-activated protein(5)
modest reduction(5)
mortality rate(5)
negative effect(5)
nonalcoholic steatohepatitis(5)
oxidative damage(5)
oxidative metabolism(5)
oxidative phosphorylation(5)
pancreatic progenitor(5)
paradigm shift(5)
pharmacological therapy(5)
potential risk(5)
practical patient management(5)
promoter region(5)
prospective cohort(5)
prospective data(5)
prospective design(5)
protein response(5)
protein synthesis(5)
randomized placebo-controlled(5)
randomized trial(5)
receptor substrate(5)
reduced expression(5)
regression analysis(5)
response relationship(5)
rheumatoid arthritis(5)
sex difference(5)
significant impact(5)
small increase(5)
study population(5)
subsequent development(5)
substantial reduction(5)
systematic evaluation(5)
testosterone propionate(5)
therapeutic approach(5)
tight control(5)
unique opportunity(5)
western blot analysis(5)
white adipose tissue(5)
written consent(5)
10-year follow-up(4)
abdominal obesity(4)
ad libitum(4)
ad libitum access(4)
add-on therapy(4)
adoptive transfer(4)
all-cause death(4)
arcuate nucleus(4)
aromatic amino(4)
arterial stiffness(4)
aspartic acid(4)
baseline data(4)
big data(4)
biliopancreatic diversion(4)
brain structure(4)
capillary density(4)
cardiovascular health(4)
cardiovascular protection(4)
causal association(4)
cell biology(4)
cell function(4)
central laboratory(4)
cerebrovascular disease(4)
chronic autoimmune disease(4)
clinical diagnosis(4)
clinical experience(4)
clinical impact(4)
clinical inertia(4)
clinical information(4)
clinical management(4)
clinical relevance(4)
clinical risk(4)
clinical type(4)
clinical utility(4)
cognitive dysfunction(4)
cognitive impairment(4)
combined data(4)
compensatory mechanism(4)
comprehensive picture(4)
comprehensive update(4)
confocal microscopy(4)
confounding effect(4)
发布时间
2016(1,139)
2015(868)
2019(740)
2018(667)
2014(571)
2017(478)
2002(1)
2009(1)
2010(1)
文档类型
PDF(56)
DOC(X)(0)
PPT(X)(0)
XLS(X)(0)
TEXT(0)
语言种类
英语(4459)
德语(1)
法语(2)
日语(0)
汉语(0)
其他(4)
发布时间跨度
从
到
